NCT04846868: Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
- State
- Completed
- Phase
- Phase 3
- People
- 620 taking part
- Started
- 8 Sep 2021
- Primary completion
- 17 Sep 2024
- Arms
- Iclepertin 10 mg
- Results
- Posted on the registry
- 15 Apr 2021: Trial registered
- 8 Sep 2021: Trial started
- 1 Oct 2024: Trial completed
- 5 Nov 2025: Trial results posted